Healthcare • NASDAQ
According to Zyberno, Lantheus Holdings, Inc. (LNTH) is not a buy — GOOD BUSINESS (74/100) with a negative Margin of Safety of -56.9% and a Brina Gap of -21.6% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, Lantheus Holdings, Inc. (LNTH) trades at $100.77 against an estimated intrinsic value per share of $64.23 — a -56.9% Margin of Safety based on Owner Earnings of $377.11M TTM, projected at -1.8% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -21.6% weakens the case: based on the company's ROIC (18.7%) and reinvestment rate (-54.1%), the business can fundamentally grow at -10.1% — but the current enterprise value implies the market expects 11.5%. This places LNTH in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -10.2% annually.
Over the trailing twelve months, LNTH generated $377.11M in Owner Earnings. Capital was deployed as follows: $300.02M returned via share buybacks, $30.60M invested in capital expenditures. Reinvestment rate: -54.1%. Owner Earnings have declined at 1.8% annually over the trailing five years using log-linear regression.